Heumos, Lukas https://orcid.org/0000-0002-8937-3457
Ji, Yuge
May, Lilly https://orcid.org/0009-0004-4337-2338
Green, Tessa D. https://orcid.org/0000-0002-6075-2058
Peidli, Stefan
Zhang, Xinyue
Wu, Xichen
Ostner, Johannes
Schumacher, Antonia https://orcid.org/0009-0001-8976-4626
Hrovatin, Karin https://orcid.org/0000-0003-3319-9645
Müller, Michaela https://orcid.org/0000-0002-1401-1785
Chong, Faye
Sturm, Gregor https://orcid.org/0000-0001-9584-7842
Tejada, Alejandro
Dann, Emma
Dong, Mingze https://orcid.org/0000-0001-7367-6819
Pinto, Gonçalo
Bahrami, Mojtaba https://orcid.org/0009-0003-0151-5196
Gold, Ilan
Rybakov, Sergei
Namsaraeva, Altana
Moinfar, Amir Ali https://orcid.org/0009-0005-4680-2724
Zheng, Zihe
Roellin, Eljas https://orcid.org/0009-0002-4181-5516
Mekki, Isra
Sander, Chris
Lotfollahi, Mohammad https://orcid.org/0000-0001-6858-7985
Schiller, Herbert B.
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Article History
Received: 4 August 2024
Accepted: 16 October 2025
First Online: 31 December 2025
Competing interests
: L.H. and S.R. are employees of LaminLabs. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Omniscope Ltd and has ownership interest in Dermagnostix GmbH and Cellarity. C.S. is on the scientific advisory board of CytoReason Ltd. S.P. consults for Relation Therapeutics. T.D.G. is an employee of KiraGen Bio. G.S. is an employee of Boehringer Ingelheim International Pharma GmbH. M.L. consults for Santa Ana Bio, owns interests in Relation Therapeutics and is co-founder and equity holder at AIVIVO. The other authors declare no competing interests.